David Linetsky - Dec 16, 2024 Form 4 Insider Report for Phreesia, Inc. (PHR)

Role
SVP, Life Sciences
Signature
/s/ Allison Hoffman by Power of Attorney for David Linetsky
Stock symbol
PHR
Transactions as of
Dec 16, 2024
Transactions value $
-$2,400
Form type
4
Date filed
12/18/2024, 08:30 PM
Previous filing
Dec 13, 2024
Next filing
Dec 19, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHR Common Stock Sale -$871 -35 -0.39% $24.88 8.94K Dec 16, 2024 By Spouse F1, F2
transaction PHR Common Stock Sale -$1.48K -59 -0.66% $25.04 8.88K Dec 17, 2024 By Spouse F1, F3
transaction PHR Common Stock Sale -$52 -2 -0.02% $25.77 8.88K Dec 17, 2024 By Spouse F1, F4
holding PHR Common Stock 188K Dec 16, 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the holder's tax withholding obligations in connection with the settlement of an award of restricted stock units.
F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.415 to $25.18 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.60 to $25.55 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.665 to $25.915 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.